U.S., March 7 -- ClinicalTrials.gov registry received information related to the study (NCT06861855) titled 'Prognosis of METTL-14 in Endometrial Carcinoma' on Feb. 22.
Brief Summary: 1. To evaluate immunohistochemical expression of METTL14 in type1 endometrial carcinoma.
2. To evaluate the correlation between METTL14 expression and clinicopathological parameters of patients with type 1endometrial carcinoma such as tumor grade, lymhovascular invasion, age of pateints, tumor stage, presence of myometrial invasion and presence of cervical stroma affection.
3. To assess correlation of METTL-14 expression with disease free survival and overall survival.
Study Start Date: Feb. 27
Study Type: OBSERVATIONAL
Condition:
Endometrial Cancer
End...